Verita Healthcare Group Ltd (“VERITA” or “VHG”) today announced its acquisition of a 70% shareholding in Australia Vitamin and Sports Nutrition Pty Ltd (“AVS”).

BACKGROUND

AVS provides a range of services relating to Health Foods, Supplements, Vitamins and Complementary Medicines; from sourcing, supplying, packaging and contract manufacturing to development of customised products and innovative formulations. AVS’ specific areas of competence and interest support the growth in demand for organic, natural ingredients such as Super Foods and high-quality Supplements, and they have quickly established themselves as trusted suppliers to major brands in the Australian healthcare market as well as fast-growing specialist start-up brands.

Head-quartered in Singapore, VERITA specialises in next-generation customised, preventative healthcare – from advanced diagnostics, disease prevention and longevity medicine to integrative oncology – all designed to help clients extend healthy lifespans and optimise performance.

STRENGTH IN OVERSEAS MARKET

AVS is VERITA’s fourth investment in Australia and it complements the Group’s fast-expanding range of high-quality products that underpin the preventative, personalised health, wellness and anti-aging solutions offered across their international healthcare platform.

Australian annual complementary medicine sales now exceed A$4.7 billion representing a compound annual growth rate of 27% and AVS is well-positioned to service the four main categories of Vitamin and Dietary Supplements, Sports Nutrition, Herbal and Traditional Products, and Weight Loss. The global complementary medicine market is expected to reach a value of US$115 billion by 2020.

Julian Andriesz, CEO of the Verita Healthcare Group, said “AVS epitomizes the reasons why Australian manufactured products are highly regarded regionally for quality and safety and we will help them ride the explosive global growth in demand for supplement and nutritional products. The acquisition of AVS underlines our commitment to providing high quality products as part of our vertically integrated, holistic healthcare offering. VERITA is fast becoming a leader in the global preventative healthcare market and we are committed to empowering our clients to improve their health and wellbeing through the latest evidence-based treatments, products, and technologies.

“The team at AVS have built a strong reputation amongst their customer base for integrity, quality and service which aligns with VERITA’s philosophy and culture. We look forward to leveraging our synergies and developing a strong partnership.”

Mikko Helle, General Manager and owner of AVS, said “VERITA’s acquisition of AVS will help drive the continued growth of our business, across Australia and into the Asia Pacific region”.

Media Contact:
Simon Potter +852 650 12933 [email protected]

ABOUT VERITA HEALTHCARE GROUP (VHG)

Verita Healthcare Group is the first vertically integrated International healthcare company focused on Integrative and Preventative Medicine. VERITA own oncology clinics in Asia, Europe and North America (“Verita Life”) and Health and Wellness clinics (including Advanced Diagnostics, Aesthetics, Disease prevention, Anti-aging and performance improvement, “Verita Health”). VERITA are also involved in Medical Tourism to ensure customers can find the best possible healthcare at an affordable price. VERITA have 23 current Research and Development collaborations with top medical and science universities internationally and are building an analytical platform for improving both diagnostic and prognostic capabilities by improving the overall outcome for patients and customers (“Verita Wisdom”). The Wisdom platform will feedback data to enhance the efficacy of the Verita’s products division (“Verita Innovate”) which includes compound pharmaceutical, cosmeceutical and nutraceutical manufacturing. This improves speed to market and customer experience.

For more information, please visit:
http://group.verita.com/en/

For a short video introduction, please visit:
https://www.youtube.com/watch?v=010SlYQ79J8&frags=pl%2Cwn

About Australia Vitamin and Sports Nutrition (AVS):

Australian Vitamin & Sports Nutrition Pty Ltd has grown to be one of the largest and most successful independently owned contract manufacturers in Australia. As an independent Contract Food, Vitamin, Supplement and Complementary Medicine Manufacturing and Sourcing operation, AVS offers comprehensive services to brands looking for an alternate supplier or to those looking for new concepts. AVS Nutrition has been built from a combined experience of more than 30 years in manufacturing and regulatory affairs in the food and pharmaceutical industries. The vision is to deliver customers a high-quality product, along with a level of customer service and satisfaction beyond any competitor in the market.

For more information, please visit:
https://avsnutrition.com.au

vitamin sports nutrition, complementary medicine, AVS
01

Verita Healthcare Completes Acquisition of AVS Nutrition Continuing Australian Expansion in High-quality Manufacturing

September 11, 2018

Verita Healthcare Group Ltd (“VERITA” or “VHG”) today announced its acquisition of a 70% shareholding in Australia Vitamin and Sports Nutrition Pty Ltd (“AVS”).

BACKGROUND

AVS provides a range of services relating to Health Foods, Supplements, Vitamins and Complementary Medicines; from sourcing, supplying, packaging and contract manufacturing to development of customised products and innovative formulations. AVS’ specific areas of competence and interest support the growth in demand for organic, natural ingredients such as Super Foods and high-quality Supplements, and they have quickly established themselves as trusted suppliers to major brands in the Australian healthcare market as well as fast-growing specialist start-up brands.

Head-quartered in Singapore, VERITA specialises in next-generation customised, preventative healthcare – from advanced diagnostics, disease prevention and longevity medicine to integrative oncology – all designed to help clients extend healthy lifespans and optimise performance.

STRENGTH IN OVERSEAS MARKET

AVS is VERITA’s fourth investment in Australia and it complements the Group’s fast-expanding range of high-quality products that underpin the preventative, personalised health, wellness and anti-aging solutions offered across their international healthcare platform.

Australian annual complementary medicine sales now exceed A$4.7 billion representing a compound annual growth rate of 27% and AVS is well-positioned to service the four main categories of Vitamin and Dietary Supplements, Sports Nutrition, Herbal and Traditional Products, and Weight Loss. The global complementary medicine market is expected to reach a value of US$115 billion by 2020.

Julian Andriesz, CEO of the Verita Healthcare Group, said “AVS epitomizes the reasons why Australian manufactured products are highly regarded regionally for quality and safety and we will help them ride the explosive global growth in demand for supplement and nutritional products. The acquisition of AVS underlines our commitment to providing high quality products as part of our vertically integrated, holistic healthcare offering. VERITA is fast becoming a leader in the global preventative healthcare market and we are committed to empowering our clients to improve their health and wellbeing through the latest evidence-based treatments, products, and technologies.

“The team at AVS have built a strong reputation amongst their customer base for integrity, quality and service which aligns with VERITA’s philosophy and culture. We look forward to leveraging our synergies and developing a strong partnership.”

Mikko Helle, General Manager and owner of AVS, said “VERITA’s acquisition of AVS will help drive the continued growth of our business, across Australia and into the Asia Pacific region”.

Media Contact:
Simon Potter +852 650 12933 [email protected]

ABOUT VERITA HEALTHCARE GROUP (VHG)

Verita Healthcare Group is the first vertically integrated International healthcare company focused on Integrative and Preventative Medicine. VERITA own oncology clinics in Asia, Europe and North America (“Verita Life”) and Health and Wellness clinics (including Advanced Diagnostics, Aesthetics, Disease prevention, Anti-aging and performance improvement, “Verita Health”). VERITA are also involved in Medical Tourism to ensure customers can find the best possible healthcare at an affordable price. VERITA have 23 current Research and Development collaborations with top medical and science universities internationally and are building an analytical platform for improving both diagnostic and prognostic capabilities by improving the overall outcome for patients and customers (“Verita Wisdom”). The Wisdom platform will feedback data to enhance the efficacy of the Verita’s products division (“Verita Innovate”) which includes compound pharmaceutical, cosmeceutical and nutraceutical manufacturing. This improves speed to market and customer experience.

For more information, please visit:
http://group.verita.com/en/

For a short video introduction, please visit:
https://www.youtube.com/watch?v=010SlYQ79J8&frags=pl%2Cwn

About Australia Vitamin and Sports Nutrition (AVS):

Australian Vitamin & Sports Nutrition Pty Ltd has grown to be one of the largest and most successful independently owned contract manufacturers in Australia. As an independent Contract Food, Vitamin, Supplement and Complementary Medicine Manufacturing and Sourcing operation, AVS offers comprehensive services to brands looking for an alternate supplier or to those looking for new concepts. AVS Nutrition has been built from a combined experience of more than 30 years in manufacturing and regulatory affairs in the food and pharmaceutical industries. The vision is to deliver customers a high-quality product, along with a level of customer service and satisfaction beyond any competitor in the market.

For more information, please visit:
https://avsnutrition.com.au

hanako, mobile health screening platform
01

Verita Acquires Stake in Hanako

July 18, 2018

Singapore, 17 July 2018 – Verita Healthcare Group Limited (“Verita” or the “Company” and together with its subsidiaries, the “Group”) has made a strategic equity investment in Hanako GmbH (Hanako).

BACKGROUND

Hanako, a leading preventative health services provider from Germany, has developed a sophisticated mobile health screening platform offering personal check-ups and assessments on-site at corporates.

Their innovative platform uses world-class portable MedTech devices to precisely capture personal health data using evidence-based examinations, then deliver personalised health informatics based on AI-enabled analysis and reporting in real-time. Their doctor rounds off each check-up with a detailed consultation on what the results mean, and what the individual should do next to address any health risks or issues identified.

With the surge in preventable chronic diseases accounting for 75% of deaths worldwide, and associated healthcare inflation adding unsustainable pressure to global economies, disease prevention is a hot topic affecting families, employers, insurers and governments.

Hanako Medical Director Prof. Uwe Nixdorff says “Many chronic disease conditions can be detected early and avoided through modifying lifestyle and harnessing medical technology to better monitor and manage health indicators. The need to change from reactive disease management into proactive disease prevention is urgently needed. Hanako arms individuals with the information they need to precisely understand their health, and knowledge of what they should do to prevent or reverse chronic disease.”

STRENGTH IN OVERSEAS MARKET

Hanako’s growing European client base includes large MNCs and they are now collaborating with Verita for international growth. Verita is an award-winning, global leader in healthcare that aims to combine the best medical technologies and scientific innovations with a personalised, preventive and integrative approach.

Under its “Verita Wisdom” advanced diagnostics offering, Verita is integrating Hanako’s scalable platform within its global Verita Health centres, starting with Bangkok which launched in early July 2018. Feedback from Verita’s clients on its new service has been very positive.

“Intelligently combining computer learning with human medical knowledge to ensure that patients’ health issues and risks are identified and proactively addressed as early as possible to optimally support individual health goals and help prevent chronic diseases aligns with our vision. We are positioned as a leading global provider of precise, preventative health solutions and Verita Wisdom, powered by Hanako’s platform, is an ideal extension to Verita’s holistic service portfolio for next-generation healthcare”, CEO Verita Healthcare Group Julian Andriesz said.

Verita and Hanako have also agreed to partner and roll-out mobile health screenings to corporations and insurance companies internationally.

Hanako Commercial Director Michael Mayr added “In Verita Healthcare Group, we are delighted to have found an investor who fits perfectly with our corporate values and with whom we will jointly drive Hanako’s strategic orientation and international success”.